{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:55:27Z","timestamp":1781711727001,"version":"3.54.5"},"reference-count":12,"publisher":"Norwegian Medical Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.25.0487","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:15:12Z","timestamp":1766405712000},"source":"Crossref","is-referenced-by-count":0,"title":["A man in his 60s with immunodeficiency and hepatitis"],"prefix":"10.4045","volume":"146","author":[{"given":"Caroline","family":"Hvitmyhr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Fjeldstad","family":"Enga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"\u00d8verb\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5vard","family":"Midgard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag Henrik","family":"Reikvam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"ref=1","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Semaglutide: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548574\/ Lest 30.4.2025."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Freyer\u00a0CW, Porter\u00a0DL. Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies. J Allergy Clin Immunol 2020; 146: 940\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32771558&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jaci.2020.07.025","DOI":"10.1016\/j.jaci.2020.07.025"},{"key":"ref=3","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol 2018; 68: 1256\u201371. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=29609832&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jhep.2018.03.005"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Horvatits\u00a0TB, Schuebel\u00a0N, Pischke\u00a0S et al. Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy. Hepat Mon 2023; 23. doi: 10.5812\/hepatmon-130865. Crossref: http:\/\/dx.doi.org\/10.5812%2Fhepatmon-130865","DOI":"10.5812\/hepatmon-130865"},{"key":"ref=5","unstructured":"WHO. Hepatitis E. Fact Sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-E Lest 28.4.2025."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Lange\u00a0H, \u00d8verb\u00f8\u00a0J, Borgen\u00a0K et al. Hepatitis E in Norway: seroprevalence in humans and swine. Epidemiol Infect 2017; 145: 181\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27671461&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1017%2FS0950268816002144","DOI":"10.1017\/S0950268816002144"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Ols\u00f8y\u00a0IB, Henriksen\u00a0S, Weissbach\u00a0FH et al. Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Troms\u00f8 study. Med Microbiol Immunol 2019; 208: 715\u201325. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30903372&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00430-019-00599-5","DOI":"10.1007\/s00430-019-00599-5"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Kamar\u00a0N, Garrouste\u00a0C, Haagsma\u00a0EB et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21354150&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1053%2Fj.gastro.2011.02.050","DOI":"10.1053\/j.gastro.2011.02.050"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Kamar\u00a0N, Mansuy\u00a0JM, Cointault\u00a0O et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8: 1744\u20138. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18557740&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1600-6143.2008.02286.x","DOI":"10.1111\/j.1600-6143.2008.02286.x"},{"key":"ref=10","unstructured":"Kran AMBKA, Barlinn R. Tylden G et al. Strategim\u00f8te 2023: Virale hepatitter \u2013 en oppdatering. https:\/\/www.fhi.no\/publ\/2024\/strategimote-2023-virale-hepatitter--en-oppdatering\/ Lest 30.10.2025."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Chutaputti\u00a0A. Adverse effects and other safety aspects of the hepatitis C antivirals. J Gastroenterol Hepatol 2000; 15 (Suppl): E156\u201363. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10921400&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046%2Fj.1440-1746.2000.02114.x","DOI":"10.1046\/j.1440-1746.2000.02114.x"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Cornberg\u00a0M, Pischke\u00a0S, M\u00fcller\u00a0T et al. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study. J Hepatol 2020; 73: 696\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32624195&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jhep.2020.05.020","DOI":"10.1016\/j.jhep.2020.05.020"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["En mann i 60-\u00e5rene med immunsvikt og hepatitt"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:30:59Z","timestamp":1781710259000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2025\/12\/noe-laere-av\/en-mann-i-60-arene-med-immunsvikt-og-hepatitt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.25.0487","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}